ACCESS TO PEPTIDE REGIONS OF A SURFACE MUCIN (MUC1) IS REDUCED BY SIALIC ACIDS

被引:38
|
作者
HO, JJL [1 ]
CHENG, S [1 ]
KIM, YS [1 ]
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA
关键词
D O I
10.1006/bbrc.1995.1738
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mucinous glycoproteins are present on the surfaces of tumor cells. Knowledge of which parts of the mucin molecule are accessible targets for cells of the immune system is important in the development of successful therapeutic approaches. One breast (ZR-75-1), two colon (Colo 205 and SW1116), and three pancreas (Capan-2, HPAF and SW1990) cancer cell lines were examined. The reactivities of antibodies HMFG-2, specific for the tripeptide (DTR) in the 20 amino acid tandem repeat of MUC1, and SM-3 (PDTRP) were greatly enhanced by pre-treating cells with an inhibitor of O-glycosylation, benzyl-alpha-N-acetylgalactosamide. However, desialylation of cell surfaces with neuraminidase or pre-treatment with an inhibitor of carbohydrate processing, monensin, also greatly enhanced the reactivities of HMFG-2, SM-3 and HMFG-1 (PDTR). Thus, sialic acids on termini of neighboring oligosaccharides significantly limit access to the peptide region recognized by antibodies HMFG-1/2 and SM-3. (C) Academic Press, Inc.
引用
收藏
页码:866 / 873
页数:8
相关论文
共 50 条
  • [21] Significance of MUC1 and MUC2 mucin expression in colorectal cancer
    Ajioka, Y
    Allison, LJ
    Jass, JR
    JOURNAL OF CLINICAL PATHOLOGY, 1996, 49 (07) : 560 - 564
  • [22] Regulation of MUC1 mucin gene by bile acids in human esophageal adenocarcinomatous cells and tissues
    Piessen, G
    Hémon, B
    Leteurtre, E
    Triboulet, JP
    Mariette, C
    Van Seuningen, I
    FASEB JOURNAL, 2005, 19 (05): : A1527 - A1527
  • [23] Cytotoxic T lymphocytes from humans with adenocarcinomas stimulated by native MUC1 mucin and a mucin peptide mutated at a glycosylation site
    Wright, SE
    Kilinski, G
    Talib, G
    Lowe, KE
    Burnside, JS
    Wu, JY
    Dolby, N
    Dombrowski, KE
    Lebkowski, JS
    Philip, R
    JOURNAL OF IMMUNOTHERAPY, 2000, 23 (01): : 2 - 10
  • [24] Expression of MUC1 mucin on activated human T cells: Implications for a role of MUC1 in normal immune regulation
    Agrawal, B
    Krantz, MJ
    Parker, J
    Longenecker, BM
    CANCER RESEARCH, 1998, 58 (18) : 4079 - 4081
  • [25] RETRACTION: MUC1 expressing tumor growth was retarded after human mucin 1 (MUC1) plasmid DNA immunization
    Son, H. Y.
    Jeong, H. K.
    Apostolopoulos, V
    Kim, C. W.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2025, 39
  • [26] Immunogenicity of the hydrophilic region of the MUC1 mucin protein core
    Price, MR
    Petrakou, E
    Sekowski, M
    Murray, A
    ONCOLOGY REPORTS, 1997, 4 (02) : 337 - 339
  • [27] Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas
    Baldus, SE
    Zirbes, TK
    Engel, S
    Hanisch, FG
    Mönig, SP
    Lorenzen, J
    Glossmann, J
    Fromm, S
    Thiele, J
    Pichlmaier, H
    Dienes, HP
    INTERNATIONAL JOURNAL OF CANCER, 1998, 79 (02) : 133 - 138
  • [28] Modulation of apical membrane trafficking of the transmembrane mucin MUC1
    Hughey, RP
    Kinlough, CL
    Bruns, JB
    Poland, PA
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 509A - 510A
  • [29] Identification of Pseudomonas aeruginosa flagellin as an adhesin for Muc1 mucin
    Lillehoj, EP
    Kim, BT
    Kim, KC
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2002, 282 (04) : L751 - L756
  • [30] Synthesis and antibody recognition of mucin 1 (MUC1)-α-conotoxin chimera
    Drakopoulou, E
    Uray, K
    Mezo, G
    Price, MR
    Vita, C
    Hudecz, F
    JOURNAL OF PEPTIDE SCIENCE, 2000, 6 (04) : 175 - 185